Within a few years the reduced deuterium content preparation can be an anti-cancer drug
The AHYD Rákkutató és Gyógyszerfejlesztő Kft. (AHYD Cancer Research and Drug Development Ltd.) has taken another significant step towards the registration of the reduced deuterium content water (DDW) as an anticancer medicine.
The total value of the world-wide unique pharmaceutical investment is more than 250 million HUF. The investment was implemented with the help of the Primus Capital Kockázati Tőkealap-kezelő Zrt. (Primus Capital Venture Capital Fund Management Ltd.). The European Union also supported the project with 16.644 million HUF.
Related news
Three global studies – one analysis
After two years of absence SIAL Paris, the biggest trade…
Read more >
Top 10 Healthiest Countries In Europe
A recent health study carried out by Snuff Store rated…
Read more >
Healthy food is important to 66 percent of Hungarians
Every third Hungarian made a devastating statement about their health…
Read more >Related news
The Széchenyi Enterprise of the Year 2022: The “Special Family Award” was awarded to the publisher of Trade magazine
The “Széchenyi Enterprise of the Year” award was announced for…
Read more >
The Hungarian management of Henkel Consumer Brands was established under the management of Zsuzsanna Szak
Following Henkel’s sustainable growth strategy, it merged its Laundry &…
Read more >
The VALMAR #challenge won an award
Last fall, the #stabilosinesszavak challenge was launched on TikTok, and…
Read more >
